• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Pediatric liver tumors gobble up FDG

Article

FDG-PET imaging may have a place for staging primary hepatic malignancies in children.

FDG-PET imaging may have a place for staging primary hepatic malignancies in children.

Dr. Rajen J. Mody and colleagues at the University of Michigan Health System, Ann Arbor, imaged seven children with pathologically proven hepatic malignancies. Six of the seven exhibited abnormal FDG uptake. Liver tumor was confirmed in three patients who underwent partial hepatic resection and in one patient who had a brain biopsy. Uptake in one patient was due to necrotizing granulomas, and another patient's images were suboptimal due to noncompliance with fasting.

The researchers concluded that FDG-PET imaging in pediatrics is most useful to assess response to therapy, in following alfa fetoprotein-negative cases, and for detecting metastatic disease. The study appeared in Pediatric Blood & Cancer (published online Aug. 2 ahead of print).

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.